Neuroinflammation appeared to be modest at the early stages of AD pathogenesis, with only the astrocyte marker Ccl3 (alias MIP1-α) gene expressed at higher levels in APP/PS1 mice compared to WT mice. This evidence concerns the gene APP and Alzheimer disease.